Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
protein degradation
Biotech
Astellas’ new lab zooms in on targeted protein degradation
The Cambridge, Massachusetts building is designed to foster a statewide innovation network, consisting of incubators, biotechs and academia.
Gabrielle Masson
Sep 5, 2024 12:01pm
Erasca lays off 18%, swaps out KRAS program for fresh options
May 17, 2024 5:30am
Novartis pays $150M for Arvinas' prostate tumor protein degrader
Apr 11, 2024 8:04am
Gilead dives deeper into Nurix protein degrader collab
Apr 2, 2024 9:10am
Merck KGaA paying $16M to join C4's protein degrader hunt
Mar 4, 2024 10:18am
Firefly Bio assembles with $94M and an ADC dream team
Feb 15, 2024 8:11am
